Centro Risorse

Questa sezione contiene ricerche internazionali e può fare riferimento a indicazioni non approvate in tutte le regioni. Si prega di consultare le indicazioni approvate localmente prima dell’uso.

Filtra per:

Cerca

We’re excited to share a few key updates from Pulsenmore as we continue to expand our impact in maternal-fetal care. FDA authorization, and what it unlocks Receiving FDA De Novo

Pulsenmore introduces a transformative model for prenatal care - extending ultrasound access beyond the clinic and redefining how we reach and monitor expectant mothers.
RAMAT GAN, Israel, Nov. 3, 2025 /PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted
We are thrilled to announce our collaboration with ARC Innovation and Dr. Avi (Abraham) Tsur, MD),
Feeling your baby move is one of the most reassuring signs during pregnancy - but what happens when an anterior placenta makes that much harder?
What an incredible experience at Royal Australian and New Zealand College of Obstetricians and Gynaecologists RANZCOG 2025!

L’impulso delle notizie

Vi invitiamo a rimanere informati sugli ultimi aggiornamenti iscrivendovi alla nostra newsletter trimestrale

Domande frequenti

Domande frequenti